Using NewSpringForMe to improve quality of life for bone marrow transplant patients
Evaluation of the Impact of the Use of the Digital Solution NewSpringForMe on Transplanted Patients' Quality of Life and Support (Bone Marrow or Peripheral Stem Cells Allotransplantation)
Fonds de Dotation HTC Project · NCT06148610
This study is testing whether a new digital program can help improve the quality of life for patients getting a bone marrow transplant by providing personalized support for their physical and emotional needs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 170 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fonds de Dotation HTC Project (other) |
| Locations | 1 site (Paris) |
| Trial ID | NCT06148610 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the impact of the NewSpringForMe digital solution on the quality of life and support for patients undergoing bone marrow transplantation. It aims to provide comprehensive interdisciplinary support that addresses both the psychological and physical health needs of patients before, during, and after the transplant process. The program is designed to enhance recovery and reduce complications associated with the transplant, leveraging a personalized approach tailored to each patient's needs. The study involves collaboration among medical and paramedical experts in hematology, transplantation, and psychology.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are undergoing their first allograft bone marrow or peripheral stem cell transplant.
Not a fit: Patients under 18 or those requiring a second or third allograft will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and recovery outcomes for bone marrow transplant patients.
How similar studies have performed: While the approach of integrating digital solutions for patient support is gaining traction, this specific program is novel and has not been extensively tested in similar contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria : * at least 18 years old * with a first indication for allograft bone marrow or Peripheric Stem Cells * monitored by the adult hematology transplant department St-Louis Hospital * having signed the consent * affiliated to a social security scheme * able to understand the objectives of the study and to use a digital tool Exclusion criteria : * aged under 18 * with an indication of second or third allograft * not being affiliated to a social security scheme
Where this trial is running
Paris
- Service Hématologie Greffe Trèfle 3, Hôpital Saint-Louis, AP-HP — Paris, France (RECRUITING)
Study contacts
- Principal investigator: Régis Peffault de Latour, PU-PH — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Emilie Robert, PhD
- Email: emilie.robert@htcproject.org
- Phone: 33 4 91 11 88 53
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hematologic Diseases, Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Digital solution, Companion, Quality of life, Support, Post-transplant complications